Skip to main content

Together we are beating cancer

Donate now

News

Showing 12 out of 2996 results
scientists in a lab

Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

A woman reading a cancer information limit while waiting to see the doctor.

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

by Tim Gunn | News | 15 August 2024

15 August 2024

stained microscopic sample of stomach cancer cells

The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer. The immunotherapy drug pembrolizumab (also known as Keytruda) has been approved as an option for people with advanced gastric cancer.

by Sophie Wedekind | News | 7 August 2024

7 August 2024

the Palace of Westminster

Today, plans to reintroduce a Bill to progressively raise the age of sale of tobacco products were announced in the first King’s Speech of this new UK Government Today, plans to reintroduce a Bill to progressively raise the age of sale of tobacco products were announced in the first King’s Speech of this new UK Government

by Alizee Froguel | News | 17 July 2024

17 July 2024

Stained cervical cells viewed under the microscope

More than million more women in England could take part in cervical screening over the next three years if they were offered do-it-yourself kits, according to the YouScreen trial. More than million more women in England could take part in cervical screening over the next three years if they were offered do-it-yourself kits, according to the YouScreen trial.

by Sadaf Shafaghmotlagh, Tim Gunn | News | 17 July 2024

17 July 2024

A crowd of people looking concerned on a hot day.

More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier. More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier.

by Tim Gunn | News | 15 July 2024

15 July 2024

A stack of cigarettes, one of them smoking

The number of cancer cases caused by smoking in the UK has reached an all-time high of 160 cases every day, new analysis shows The number of cancer cases caused by smoking in the UK has reached an all-time high of 160 cases every day, new analysis shows

by Jacob Smith | News | 9 July 2024

9 July 2024

A young Nepalese girl standing among a group of women

Through the International Cancer Prevention programme, we’re helping to expand access to HPV vaccination for adolescent girls in low and middle income countries, to prevent cervical cancer. Through the International Cancer Prevention programme, we’re helping to expand access to HPV vaccination for adolescent girls in low and middle income countries, to prevent cervical cancer.

by Elle Pearson | News | 24 June 2024

24 June 2024

Visitors at the National Biomarker Centre

Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available. Today marks the opening of the Cancer Research UK National Biomarker Centre, a new state-of-the-art facility in Manchester which will help experts detect cancer at an earlier stage – when there are usually more treatment options available.

by Amy Warnock | News | 14 June 2024

14 June 2024

Cancer Research UK scientists in the lab

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

by Tim Gunn | News | 13 June 2024

13 June 2024